NGEN
NASDAQ · Pharmaceuticals
Nervgen Pharma Corp
$1.62
+0.02 (+1.25%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+671.0% upside
Low Target
$8.17
Average Target
$12.49
High Target
$18.41
Current Price
$1.62
Current
$1.62
$1.62
Target
$12.49
$12.49
$8.17
$12.49 avg
$18.41
Scenario Analysis
Bear Case
$8.17
404.3%
Low target
Base Case
$12.49
+671.0%
Avg target
Bull Case
$18.41
+1,036.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$8.49
-80.9% from high
52-Week Low
$2.71
+-40.2% from low
Target vs 52W High
$12.49
+47.1% vs high
Peer Consensus — Pharmaceuticals